FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only floxuridine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely floxuridine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing floxuridine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fludarabine phosphate 10 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing fludarabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing fludarabine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing fludarabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only fludarabine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only fludarabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fludarabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing estramustine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only estramustine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Estramustine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely estramustine phosphate (as estramustine phosphate sodium) 140 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing estramustine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only eribulin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Eribulin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing eribulin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing eribulin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only epirubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Epirubicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epirubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epirubicin hydrochloride 20 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing epirubicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing epirubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tagraxofusp (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tagraxofusp (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tagraxofusp in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tagraxofusp in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only olaratumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Olaratumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing olaratumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing olaratumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing talazoparib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Talazoparib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing oxaliplatin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only oxaliplatin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Oxaliplatin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing oxaliplatin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing gefitinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only gefitinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gefitinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing gefitinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing gemcitabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing gemcitabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only gemcitabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing glasdegib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Glasdegib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing glasdegib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only glasdegib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing idarubicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only idarubicin in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only idarubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely idarubicin hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Idarubicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely idarubicin hydrochloride 5 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely idarubicin hydrochloride 10 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely idarubicin hydrochloride 25 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing idarubicin in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing idarubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing hydroxycarbamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing hydroxycarbamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only hydroxycarbamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Hydroxycarbamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely hydroxycarbamide 500 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely hydroxycarbamide 200 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely hydroxycarbamide 300 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely hydroxycarbamide 400 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely hydroxycarbamide 1 gram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing ifosfamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing ifosfamide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only ifosfamide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ifosfamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ifosfamide 1 gram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ifosfamide 2 gram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mitobronitol (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only mitobronitol in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only mitobronitol (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mitobronitol 125 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mitobronitol in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing methotrexate Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing methotrexate in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing methotrexate in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only methotrexate in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only methotrexate in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methotrexate (as methotrexate sodium) 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methotrexate (as methotrexate sodium) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 9 of 26 Next End

This concept is not in any reference sets

Back to Start